Whalesbook
Valuation Ka Mamla Dabaya?
ICICI Securities ka kehna hai ki PCBL Chemical ka stock price abhi kaafi overvalued hai. Unhone apni rating ko 'REDUCE' kar diya hai aur target price ko ₹290 se ghatakar ₹270 kar diya hai. Brokerage ne FY27 aur FY28 ke liye EBITDA estimates ko 9-12% tak kam kar diya hai, jisse lagta hai ki future earnings current stock price ko support nahi karenge.
Stock Kitna Mehnga Hai?
Sabse badi chinta valuation ki hai. PCBL ka P/E ratio abhi 50x se 60x ke beech mein hai, jabki Indian chemical industry ka average sirf 23x hai aur competitors jaise Himadri Speciality Chemical 40-55x pe trade kar rahe hain. Matlab PCBL apne competitors se bhi kaafi upar chal raha hai. Pichhle ek saal mein stock 16% girne ke baad bhi valuation high hai.
Accha Performance, Par Kahan?
Company ka core business, carbon black, mein domestic volumes mein acchi growth dikhi hai aur margins bhi stable hain. FY27 mein is segment se high single-digit volume growth aur double-digit EBITDA expansion ki ummeed hai. US tariffs kam hone aur cost cutting se bhi help milegi. Lekin jo specialty chemicals wala hissa hai, jo Aquapharm ke through manage hota hai, woh abhi bhi struggle kar raha hai. Company ka target hai ki Aquapharm FY27 ke end tak ₹750 million quarterly EBITDA kamaye, jo ki ek bada challenge hai.
Trade Deal Ka Asar Aur Crude Oil
Ek achhi khabar yeh hai ki US-India trade deal ke baad Indian exports par tariffs 50% se kam hokar 18% ho gayi hai, jisse exports ko boost mil sakta hai. Par carbon black prices crude oil ke prices se linked hain, jismein volatility rehti hai. Domestic market mein demand acchi hai, jo ek stability de sakti hai.
Risk Factor
Sabse bada risk hai PCBL ka persistently high valuation. Aquapharm ki performance aur debt metrics pe negative outlook bhi ICRA ne February 2026 mein diya tha. Stock 16% girne ke baad bhi valuation mehnga hai aur specialty chemicals mein recovery kaafi mushkil lag rahi hai.